Modulation of engrafting stem cells by gene therapy
There is much evidence for the capacity of donor marrow stem cells to engraft and reconstitute non-hematopoietic organs as well as recipient bone marrow. There are stem cell-specific determinants of engraftment. Enhanced engraftment capacity of quiescent cells has been attributed to decreased cell cycling and reduced differentiation capacity, 1, 2 but is also associated with resistance to the oxidative stress which accompanies harvest and transplant. 3, 4 Engrafting cells are exposed to the toxic, oxidative stress inducing microenvironment of the irradiated or cytotoxic drug-treated host. There is increasing evidence that the intrinsically limited competitive repopulation capacity of donor cells may be enhanced by increasing their resistance to oxidative stress. [5] [6] [7] Mice deficient in p21 cip/wafl or p18 INCÀ4C demonstrate altered self-renewal capacity and altered competitive repopulation capacity compared to marrow stem cells from litter mates not lacking these tumor suppressor gene or cell cycle altering gene functions. 8, 9 Antioxidant approaches toward enhancing stem cell protection include transfection of the transgenes for manganese superoxide dismutase (MnSOD), catalase, glutathione, peroxidase, metallothione and others. 10, 11 While there is some protective effect of antioxidant transgene expression shown with respect to clonogenic survival of cells in culture, 12, 13 no assays of stem cell competitive repopulation capacity have been reported. In contrast, when the microenvironment is induced to overexpress antioxidants by gene therapy, the homing capacity for engrafting stem cells, and also survival of residual stem cells, is enhanced. 12 Gene therapy approaches toward directly protecting stem cells represent an attractive strategy; 10, 11, 14 however, there is also evidence that gene therapy-mediated protection of the microenvironment may also be of value. Expression of the MnSOD transgene by plasmid liposome transfection of the recipient has been shown to enhance capacity to reconstitute the irradiated esophagus and other tissues with donor bone marrow origin cells. 12, 15 In these experiments, MnSOD-plasmid liposomes (PL)-mediated transgene expression in the recipient microenvironment also increased surviving recipient stem cell repopulation capacity. 13, 15 Whether overexpression of an antioxidant transgene in hematopoietic stem cells protects self-renewal capacity is not yet known. Whether overexpression of antioxidant transgenes increases the baseline antioxidant stores in stem cells and if such overexpression correlates with improved engraftment capacity in the irradiated or drugtreated marrow microenvironment is also not known. The present review will address the challenge associated with improving the effectiveness of antioxidant gene therapy and other gene therapy protection strategies for stem cell protection.
Preparing the stem cell niche for engraftment of bone marrow-derived stem cells
There is a critical role of the organ-specific microenvironment in hematopoietic stem cell engraftment and differentiation 16, 17 ( Figure 1 ). The concept of a limited number of niches/specific environmental sites for the multilineage or totipotential hematopoietic stem cells derives from work in experimental animals demonstrating a plateau maximum number of pluripotent stem cells which can engraft. 5, 7, 18 The competitive repopulation assay compares two purified (low-density gradient purified) hematopoietic stem cell populations, injected intravenously into a third irradiated murine host. [5] [6] [7] By comparing different ratios of the two donor stem cell populations for genotypic markers to distinguish them from each other and from the recipient, one can calculate the maximum number of stem cell sites in the host hematopoietic system. 5, 7, 18 However, irradiation dose dependent and organ site-specific damage to the hematopoietic microenvironment is known to selectively compromise stem cell engraftment. 5, 18, 19 Furthermore, cells of the hematopoietic microenvironment, called bone marrow stromal cells (mesenchymal stem cells, marrow stromal cells, CFU-F (colony forming unit fibroblasts)) circulate from non-irradiated or lowdose-exposed sites and can home to replace the microenvironment in a more heavily damaged site. 16 Thus, the stem cell niche can be modified in part by its own transplantation.
The specific cell type(s) within the bone marrow that represent the 'niche' for stem cell engraftment and how such cells can be induced to protect newly arrived donor or residual recipient stem cells is a subject of intense investigation 17, 20, 21 ( Figure 1 ). Cells identified in the endosteal or periphery of the marrow were shown to host the homing of donor stem cells. 20 The niche cells of the microenvironment have been identified as either osteoblasts, endothelial cells, reticular-adventitial cells or undifferentiated marrow stromal cells. 17, 20 The modulation of stem cell homing by changing the makeup of the niche provides cellular evidence for a specific subpopulation of cells in the microenvironment with capacity to support the homing of stem cells. 17, 20, 22, 23 Damage to the hematopoietic microenvironment/ hematopoietic stem cell niche by ionizing irradiation and alkalinizing agents including busulfan reveals a toxin-dose-dependent destruction of available engrafting sites, and reduces the homing of donor untreated stem cells. 2, 18 Clearing of the stem cell niche for engraftment by ionizing irradiation produces multiple effects including: (1) physical clearing of space by induced apoptosis of cells in the niche for homing of new donor cells and (2) cytokine release and signaling of repopulation by surviving recipient organ cells. These two phenomena occur in non-hematopoietic as well as hematopoietic organs. 12, [24] [25] [26] Toxicity to the non-hematopoietic organ microenvironment can facilitate engraftment or repopulation by cells from other organs including the marrow. 24, 27, 28 Exposure of the rat liver to carbon tetrachloride, followed by further damage to repopulating cells by 3-amino-fluorine alters the liver microenvironment to accept bone marrow-derived cells which are capable of differentiating into both hepatocytes and hepatic duct cells. 27 Irradiation and/or chemical injury to the stromal microenvironment of the heart, lung, esophagus and central nervous system also facilitates homing and differentiation of bone marrow-derived cells into functioning components of that organ. 18, 24 Embryonic stem cells have been substituted for bone marrow stem cells as progenitor populations in these Gene therapy stem cell protection JS Greenberger experiments, but toxicity to the recipient microenvironment limits their engraftment as well. 29 Gene therapy approaches to reduce oxidative stress effects on repopulating stem cells by the irradiated or injured organ microenvironment
Irradiation of feeder layers in tissue culture was originally thought to simply prevent cell division while allowing continual growth factor production for added non-irradiated cells by the growth-arrested cells. 21 Chronic/fibrotic responses of the recipient bone marrow in the clinical transplant patient were originally thought to be caused by interaction of engrafting with recipient cells, to progression of the original disease or to residual damage caused by irradiation or chemotherapy. 7 It is now known that ionizing irradiation and chemotherapeutic alkalinizing agents induce free radical production in cells of the microenvironment in vitro and in vivo, and that these toxic effects persist for weeks to months. 11, 15 Bystander induction of damage to engrafting cells by close proximity to irradiated or drug-treated stromal cells is known to occur not only through induction of inducible nitric oxide synthase in engrafting cells, but also to inflammatory cytokines, and can lead to genetic changes in the engrafting cells. 30 Through cytokine release, marrow stromal cells can also induce apoptosis and/or genetic damage in the engrafting cells. 21 Paradoxically, irradiation can also upregulate adhesion molecules in stromal cells which can stimulate homing of circulating cells.
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The capacity of donor stem cells to home and engraft into the ionizing irradiated or toxin-damaged recipient microenvironment depends on intact DNA damage repair systems, and antioxidant stress handling mechanisms in the engrafting cells. 8, 9 ATMÀ/À mouse hematopoietic stem cells have a deficient proliferative advantage compared to wild-type cells, engrafting into the same irradiated host which can be partially ameliorated by treating the host and/or deficient cells with the free radical scavenger N-acetyl-cysteine. 3, 4 The success of hematopoietic cell engraftment in non-myeloablated recipients may be attributable to the reduced-irradiation dose-dependent decrease in toxicity to the microenvironment while still clearing of an adequate niche by the sublethal total body irradiation. 3, 4 Oxidative stress in the hematopoietic, esophageal or pulmonary microenvironment is associated with upregulation of inflammatory cytokines, transforming growth factor b (TGFb), interleukin (IL)-1, tumor necrosis factor a (TNFa), and in some organ systems (lung) with both an acute and a delayed late response. 11 The late response may be attributable to apoptosis of a slowly proliferating cell population in the lung, the death of which stimulates a second cytokine cascade leading to homing of a second circulating stem cell population (bone marrow stromal cell/mesenchymal stem cell) which differentiates to myofibroblasts and contributes to late irradiation fibrosis. 11 Antioxidant gene therapy using MnSOD-PL that target the lung or esophagus facilitates bone marrowderived stem cell engraftment. 11 In the irradiated esophagus, treatment with MnSOD-PL enhances homing of bone marrow-derived progenitors of esophageal squamous epithelium and repopulation of the damaged esophagus. 12 In the lung, MnSOD-PL administration decreases both early and late free radical production and both episodes of inflammatory cytokine release. Decrease in the late effect reduces bone marrow stromal cell migration to the lungs and decreases pulmonary fibrosis. 15 Oxidative stress in the irradiated organ microenvironment compares in many ways to the oxidative stress of aging. 6, 31 Long-term bone marrow cultures show enhanced longevity and production of hematopoietic cells by removing components of oxidative stress either by adding catalase 32 , or removing endogenous sources of nitric oxide 33 or capacity to respond to inflammatory cytokines. 34 Treatment of bone marrow transplant recipients with antioxidants such as the free radical scavenger WR2721 (Amifostine), N-acetyl-cysteine or MnSOD-transgene before or after myeloablation improves engraftment in bone marrow and epithelial organs.
3,4,13 It is not known whether antioxidant treatment enhances engraftment by protection of the microenvironment, protection of the engrafting stem cells or protection of both populations.
There are several potential ways to protect stem cells from toxic damage. Resistance of a subset of hematopoietic stem cells to agents such as ionizing irradiation and alkalinizing agents which target cycling cells confirmed that quiescence or maintenance in the G 0 phase of the cell cycle is itself protective. [6] [7] [8] [9] The subset of rodent hematopoietic stem cells which resists total body irradiation can be identified as those cells with a lower metabolic rate, low respiratory rate, as reflected by rhodamine dye exclusion from mitochondria. 35 Stem cell hierarchy is not the same for all organspecific, self-renewing populations. A non-classical stem cell model with bronchial/alveolar stem cell populations in the lung has recently been demonstrated. 25, 31 ( Figure 2 ) Herpes simplex virus-thymidine kinase-Clara cell secreting protein (HSV-TK-CCSP) transgenic mice demonstrate gancyclovir-mediated removal of two subsets of lung stem cells specific for CCSP protein production, including a quiescent subset capable of repopulating differentiated ciliated epithelium and resisting naphthalene toxicity, and another cycling subset of lung stem cells which is naphthalene sensitive, and is in transit. Both subsets include stem cells which can repopulate multilineage cells of the lungs (Figure 3) . 25 In contrast, intestinal crypt stem cell self-renewal appears to follow the classical paradigm of stem cells as is found in the bone marrow. 31 Quiescence of intestinal crypt cells leads to exit from the stem cell compartment upon response to proliferative demands, a model similar to that of the bone marrow, skin and glandular breast epithelium. 18, 19 A confounding factor in the strategy to use gene therapy to protect stem cell subsets is the potential for overriding the protective effect through damage from contact with a toxic microenvironment into which engraftment must occur. Furthermore, techniques by which to overexpress protective transgenes in stem cells require manipulation of these cells without pushing differentiation, cell cycling or apoptosis. Several cell populations have been evaluated in models of gene therapy (Table 1) . Retro-viral transfection techniques have been suboptimal and reveal a loss of large relative Gene therapy stem cell protection JS Greenberger numbers of stem cells by the transfection techniques. 36, 37, 39 Furthermore, the subset of nucleated bone marrow cells known to contain totipotential lymphohematopoietic stem cells is difficult to isolate without pushing their differentiation, or overcoming resistance to viral vectors or other transfection methods. 42 Transient overexpression of antioxidant genes in hematopoietic progenitor cells confers protection against ionizing irradiation, TNFa and growth factor deprivation.
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MnSOD transgene overexpression in bone marrow and esophageal stem cell subsets has been achieved using plasmid liposome transfection and has been shown to confer radiation protection. 11, 13 Recent evidence indicates that mitochondrial localization of MnSOD overexpression is required for radiation protection, in that deletion of the mitochondrial localization sequence of the transgene removes radiation protection, whereas linking this sequence to the cytoplasmic copper-and zinccontaining superoxide dismutase , which is inactive in its native state, confers radioprotective capacity. 15 MnSOD overexpression in stem cells or hematopoietic progenitor cell lines elevates antioxidant stores in tissues including levels of glutathione and total cellular antioxidants which follows depletion of these stores by natural respiration-associated free radical production. 15 However, antioxidant store depletion eventually occurs Figure 2 The effect of irradiation on the lung microenvironment. The lung is shown immediately after irradiation before any cells from the bone marrow arrive (left-hand panel a). In this drawing, the lung is irradiated and the small area shown in the box contains bronchioles, and bronchial epithelial cells, which elaborate cytokines that promote migration of cells from the bone marrow through the peripheral blood. These include TGFb, TNFa and IL-1. Bone marrow-derived progenitor cells of lung epithelium are hypothesized to migrate from bone marrow and engraft into the irradiation-damaged lung (b). Irradiation of the lung has enlisted migration from the bone marrow into the lung of hematopoietic cells. These are progenitors of lung, bronchial and alveolar epithelium. Radical oxygen species (ROS) in the irradiated bronchial epithelium have effects on migrating and arriving cells in the lung microenvironment. By reducing ROS and cytokines, it is hypothesized that the microenvironment of the lung will be more hospitable to arrival of stem cells and support homing, stability, and differentiation of these stem cells to bronchial and alveolar epithelium. Late irradiation effects in the lung are shown on the right (c). The irradiated lung again releases ROS and cytokines which now elicit migration from the bone marrow of mesenchymal stem cell progenitors of lung fibroblasts. These are myoepithelial cells which contribute to the fibrotic lesion in the lung. Migration of these fibroblasts through endothelial cells into the lung results in fibrosis. The addition of antioxidants, which decrease ROS and indirectly reduce cytokine production, are also hypothesized to decrease the magnitude of migration to the lung of fibrosis-inducing cells. TGFb, transforming growth factor b; IL-1, interleukin; TNFa, tumor necrosis factor a.
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in MnSOD-overexpressing cell lines that are overwhelmed by oxidative stress and undergo apoptosis. 15 These observations suggest that protective strategies must also target the stem cell microenvironment. The organ-specific microenvironment includes not only those 'niche' supportive cells for stem cell engraftment, but also other neuronal and immunocompetent cells, all of which can either enhance or denigrate stem cell homing and engraftment. 17 In both bone marrow and other non-lymphohematopoietic organs, ionizing irradiation, and cytotoxic alkalinizing agents through their cytoreductive effects, uncover the basement membrane as a target for immune inflammatory cellular response to injury. 25 Endothelial cell swelling and decreased endothelial cellular function are followed by transendothelial migration of inflammatory cells, and release of chemotactic factors for lymphocytes, macrophages and circulating polymorphonuclear leukocyte, which further exacerbates the inflammatory response. 25 Apoptosis in cells in the irradiated environment, both stem cell and microenvironmental components, elicits a further inflammatory response. 11, 13 Protecting the microvasculature from irradiation injury protects repopulating intestinal crypt cells. FGF2 responsive endothelial cells in acid sphingomyelinaseÀ/À mice (which cannot form ceramide) show decreased apoptosis after irradiation and this indirectly protects the intestinal crypt cells. 66 Therefore, targeting endothelial cells for radiation protection offers the potential advantage of protecting potential 'niche' cells for stem cell homing, reduces free radical production, maintains blood supply and preserves oxygenation of the irradiated tissue. 11, 12, 15 The kinetics of downregulation of the inflammatory response vary between target organs, and in some cases as in the lung are biphasic with both an acute and chronic component. 11 In the days to months following irradiation, production of free radicals and release of cytokines is detected in the microenvironment of the bone marrow, esophagus and lung. 11, 15 ( Figure 3 ).
Introducing transgenes into the organspecific microenvironment to improve stem cell survival after homing
Several receptor/counter receptor interacting pairs have been shown to affect the efficiency of bone marrow hematopoietic stem cell homing to the microenvironment. 67 Vascular adhesion molecule-1 (VCAM-1), glycosyl, mannosyl, fucosyl sugar receptors, c-kit/kit ligand, granulocyte-colony-stimulating factor (G-CSF)/G-CSF receptor, FLK1/FLK1 ligand, CD34/CD34 receptor and other receptor/ligand pairs have been shown to be involved in hematopoietic stem cell homing. 67 Whether overexpression of a receptor in hematopoietic stem cells leads to improved homing has been tested in transgenic models. One problem with these types of experiments is the lack of specificity of a receptor restricted to primitive hematopoietic cells. Cycling of CD34 surface receptor on hematopoietic cells has been demonstrated and an added problem in transgenic mice is that the overexpression of one receptor can lead to downregulation of expression of others. 67 Overexpression of homing counter receptors in the hematopoietic microenvironment by gene therapy techniques has been suggested as a method by which to enhance the efficiency of engraftment. 67 The osteoblast response to para-thyroid hormone administration has been shown to stimulate increased stem cell engraftment in vivo. 17 The administration of radiolabeled, trackable hematopoietic stem cells results in initial transient homing of these cells to the lung, then a secondary clearance from the lung, and migration to bone marrow sites. 24 Furthermore, initial lodging of engrafted hematopoietic cells to reticular/adventitial cell sites in the marrow sinuses is followed by secondary migration to sites of the true hematopoietic stem cell niche. 17 Increased mobilization of hematopoietic cells from the marrow into the circulation is known to increase following G-CSF, keratinocyte growth factor (KGF) or IL-11 administration. 24 Simply increasing the numbers of available/ trafficking stem cells could in effect increase the homing to available niches in the hematopoietic microenvironment. One requirement of successful engraftment is the return of donor hematopoietic cells to a quiescent state. 8, 9, 17 Continued cycling of all engrafted cells would result in hematopoietic cell depletion, absence of serial self-renewal of stem cell and lack of stable engraftment. 5, 6, 19 The same requirement of primitive stem cell to return to the quiescent state is probably true for stem cell repopulation of intestine, lung, esophagus and skin. 17, 24 Gene therapy stem cell protection JS Greenberger
Stem cells lose self-renewal capacity with aging. Standard assays for self-renewal have documented the age-dependent decrease in both self-renewal and repopulation capacity of murine hematopoietic stem cells with aging of the host and the ontogeny of the site of moving hematopoiesis from yolk-sac to fetal liver, to spleen, and then to bone marrow. 5, 18, 19 Furthermore, estimated numbers of bone marrow stem cells from retired breeder, two-year-old mice showed decreased self-renewal capacity compared to those from newborns. 5, 18, 19 Restoration of self-renewal capacity by overexpression of antioxidant transgene products has been hypothesized to be an approach toward stem cell protection. 3, 4 Totipotential hematopoietic stem cells circulate in the umbilical cord blood, and shortly after birth the frequency of circulating cells drops significantly. 68 The mechanism of this phenomenon is unknown. In the adult, pluripotential stem cells can be induced to traffic by administration of cytotoxic alkylating agents. 2 The mechanism of mobilization and stimulation of trafficking has been shown to involve interruption of the C-kit/kit-ligand interaction in the hematopoietic stem cell niche of the bone marrow, and can be initiated by administration of high doses of G-CSF. 24 The subset of hematopoietic stem cells that survive total body irradiation has been shown to be in quiescence. 8, 9, 18, 19 5-Fluorouracil (5-FU)-resistant stem cells are radiation resistant (using 5-FU, a drug known to kill cycling cells). In contrast, busulfan is toxic for hematopoietic stem cells in quiescence. 19 Self-renewal of stem cells in the bone marrow is known to respond to the competing proliferative demands of cell growth in vivo and in vitro. 19 Protection of cells from cytotoxic therapy includes techniques by which to stimulate quiescence. Tumor cell attachment to cells of the organ-specific microenvironment induces resistance to apoptosis by Gene therapy stem cell protection JS Greenberger both chemotherapeutic agents and irradiation. Attachment of stem cells to cells of the microenvironment induces quiescence and resistance to cellular toxic agents, but it is not known whether these attachments involve the same or different mechanisms. 17, 67 G-CSF mobilizes bone marrow stem cells into the circulation and circulating umbilical cord blood stem cells are known to be cycling, but cells have the capacity to return to quiescence when homing to the hematopoietic microenvironment. 8, 9, 17, 24 Methods by which to induce stem cell quiescence through gene therapy appear to be a logical approach for stem cell protection; however, the technique by which to insert a transgene must not be toxic, and in particular should not result in loss of the subset of those cells that are being selected for protection. [69] [70] [71] [72] Bone marrow stem cells represent the 'classical' paradigm of progression from quiescent non-cycling totipotential cells to the cycling state, and then to differentiation. 31 In contrast, the non-classical model of stem cell biology is displayed by bronchopulmonary stem cells, which do not follow the same paradigm. In the lung stem cell model, the absence of experiments documenting serial transplantation capacity, competitive repopulation or other in vivo assays of stem cell biology forces the question as to whether both the transit and quiescent CCSP+ populations represent true stem cells. Both populations should be shown capable of reconstituting bronchopulmonary units in irradiated or drugtreated recipient mice, and then after secondary serial transfer in vivo and purification, should be capable of similar reconstitution in a second generation of treated recipients, then both CCSP+ populations would be classified as stem cells. In the absence of such data, the naphthalene-resistant CCSP+ subset probably represents the true pulmonary stem cells. Gene therapy approaches toward maintaining CCSP+ cells in quiescence would present a strategy for protection of cells from irradiation damage or inhaled pollutants.
Summary
Gene therapy techniques offer a potential new therapeutic modality to protect stem cells . Such approaches may include direct targeting of the stem cells and also indirect targeting of the microenvironment/niche to which the stem cell homes and must reside for return to a quiescent state. The latter approach (microenvironmental protection) offers potential advantages as the strategy of choice for stem cell protection. Toxic side effects of transgene transfer to stem cells through electroporation, plasmid liposome or viral vector transfer can be avoided through utilization of these techniques on cells of the microenvironment. The stem cell microenvironment includes marrow stromal cells, endothelial cells and supportive cells of the 'niche' for stem cell homing. The proliferative capacity of cells of the microenvironment allows for its potential use in transgenetic manipulation before cell transfer, providing for a second advantage of this system. Preliminary success with the antioxidant MnSOD transgene delivered to the microenvironment of the lung, bone marrow and esophagus supports extending this area of research into other transgenes and other organspecific microenvironments.
